Mediverify Database
.png)
.png)
Welcome to the official website of the National Medicine Regulatory Authority of Sri Lanka. We are dedicated to ensuring the safety and efficacy of medicines for the people of Sri Lanka.
The National Medicine Regulatory Authority of Sri Lanka is committed to ensuring the safety, efficacy, and quality of medicines in the country. We strive to protect public health by regulating the manufacturing, importation, distribution, and sale of medicines.
NMRA regulates medicines, medical devices, borderline products imported to and manufactured in Sri Lanka. We also regulate pharmacies. Clinical trials conducted in Sri Lanka are also regulated by us.
Find Out MoreNational Medicines Quality Assuarance of the NMRA is responsible for the analyzing of the quality of any medicine, medical device or borderline product forwarded by the Authority. It functions as an additional approved analyst when the circumstance so requires.
Find Out MorePharmacovigilance Division is responsible for monitoring and dealing with adverse drug reaction, quality failure and counterfeit medicines.
Find Out MoreInspectorate and Enforcement Division is responsible for inspecting and investigating issues pertaining to proper implementation of the provision of the NMRA Act.
Find Out MoreNational Medicines Regulatory Authority,
State Engineering Corporation Building (2nd Floor),
No. 130,
W.A.D Ramanayaka Mawatha,
Colombo 02,
Sri Lanka
Please be informed that all pharmacies-related regulatory activities done by the NMRA, including applications accepting, responsible pharmacists' interviews and issuing payment vouchers will be carried out only on Mondays, Wednesdays and Fridays from 8.30 am to 2.00 pm with effect from 2025/03/01.
National Medicines Regulatory Authority
State Engineering Corporation Building (2nd Floor),
No.130, W.A.D Ramanayaka Mawatha,
Colombo 02, Sri Lanka
National Medicines Regulatory Authority is independent authority in the Ministry of Health established in 2015 through an Act of Parliament. The NMRA is governed by a board.
We are seeking for tax consulting firm to be engaged to cater our requirements
Self prepared application with history and experience of the company along with staff qualifications and registration with your quotation details to above address on or before 13th February 2025
Notice to all Authorized Local Agents
Subject : Consideration of Average Dollar Rate for Price Approvals of MRP’s by NMRA
This is to kindly inform all authorized local agents that, as discussed with the members of the SLCPI and the Pricing Committee, the NMRA will consider the average dollar rate of the previous three months for price approvals of Maximum Retail Prices (MRPs) of medicines from January 2025 onwards.
Accordingly for the month of February 2025, the United States Dollar (USD) rate is considered as 296.74 for reviewing price details of medicines.
This decision aims to ensure fair and consistent pricing of medicines while considering the fluctuations in the exchange rate.
Please ensure that all price submissions for MRP approvals are prepared accordingly.
